New hope for painful bandage changes in rare skin disease
NCT ID NCT03730584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a numbing cream (ropivacaine) can reduce severe pain during bath and dressing changes in children and young adults with epidermolysis bullosa, a rare genetic skin condition. Ten participants applied the cream before dressing changes and reported their pain levels. The goal was to see if pain scores dropped by at least 2 points over five days, aiming to improve quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker Enfants Malades
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drop battle: which offers better dry eye relief?
- Can training ease the burden of caring for fragile skin? new study investigates.
- New combo therapy aims to heal wounds in rare skin disease
- Bubble bath breakthrough? new study tests microbubble therapy for tough skin diseases
- Stem cell trial aims to heal wounds in 'Butterfly Skin' disease
- New gel could help heal wounds in rare skin disease